Pictet Asset Management (Switzerland)’s BeOne Medicines Ltd ONC Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$22.3M	Buy	125,054 +12,114	+11%	+$2.79M	0.03%	438
2023 Q1	$24.3M	Sell	112,940 -11,270	-9%	-$2.7M	0.03%	421
2022 Q4	$27.3M	Sell	124,210 -152,208	-55%	-$27.9M	0.04%	379
2022 Q3	$37.3M	Sell	276,418 -32,501	-11%	-$5.58M	0.06%	320
2022 Q2	$50M	Buy	308,919 +231,976	+301%	+$36.2M	0.07%	276
2022 Q1	$14.5M	Sell	76,943 -132,558	-63%	-$28.2M	0.02%	561
2021 Q4	$56.8M	Sell	209,501 -103,893	-33%	-$35.1M	0.06%	325
2021 Q3	$8.9M	Buy	+313,394	New	+$102M	0.01%	696

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ONC Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its BeOne Medicines Ltd (ONC) stake by 11% in Q2 2023, buying an estimated $2.79M and bringing the position to 125,054 shares worth $22.3M. The position accounts for 0.03% of the portfolio, ranked #438.

Pictet Asset Management (Switzerland) first reported a position in ONC in Q3 2021 and has held it in 8 quarters since. The position peaked at $56.8M in Q4 2021. 209 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

Pictet Asset Management (Switzerland) held 125,054 shares of BeOne Medicines Ltd worth $22.3M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 12,114 BeOne Medicines Ltd shares in Q2 2023, an estimated $2.79M.
BeOne Medicines Ltd made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #438 holding.
Pictet Asset Management (Switzerland) first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s BeOne Medicines Ltd position peaked at $56.8M in Q4 2021.
209 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.